Antioxidant Use in Diabetes to Reduce Oxidative Stress
Supplementation of N-acetylcysteine and Arachonic Acid in Type 1 Diabetes to Determine Changes in Oxidative Stress
Sponsor: University of Maryland, Baltimore
Terminated
COVID
Other terminated trials from University of Maryland, Baltimore
A EARLY_PHASE1 clinical study on Ameliorating Oxidative Stress in Type 1 Diabetes, this trial is terminated or withdrawn. The trial is conducted by University of Maryland, Baltimore and has accumulated 10 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2024 — Present [monthly]
Terminated EARLY_PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Terminated EARLY_PHASE1
-
Apr 2022 — Jul 2024 [monthly]
Terminated EARLY_PHASE1
Status: Active Not Recruiting → Terminated
-
Jan 2021 — Apr 2022 [monthly]
Active Not Recruiting EARLY_PHASE1
-
Nov 2020 — Jan 2021 [monthly]
Active Not Recruiting EARLY_PHASE1
Status: Recruiting → Active Not Recruiting
▶ Show 5 earlier versions
-
Sep 2019 — Nov 2020 [monthly]
Recruiting EARLY_PHASE1
-
Apr 2019 — Sep 2019 [monthly]
Recruiting EARLY_PHASE1
Status: Not Yet Recruiting → Recruiting
-
Jun 2018 — Apr 2019 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Mar 2017 — Jun 2018 [monthly]
Not Yet Recruiting EARLY_PHASE1
-
Feb 2017 — Mar 2017 [monthly]
Not Yet Recruiting EARLY_PHASE1
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University of Maryland, Baltimore
For direct contact, visit the study record on ClinicalTrials.gov .